0

Journal Articles

in Thromboembolism/Anticoagulation
 141-149 of 149 Articles
Editorial |  January 13, 1999
Empowering Patients to Monitor and Manage Oral Anticoagulation Therapy
Jack E. Ansell, MD
JAMA. 1999;281(2):182-183. doi:10.1001/jama.281.2.182.
Original Contribution |  January 13, 1999 FREE
A Structured Teaching and Self-management Program for Patients Receiving Oral Anticoagulation:  A Randomized Controlled Trial
Peter T. Sawicki, MD, PhD; for the Working Group for the Study of Patient Self-Management of Oral Anticoagulation
JAMA. 1999;281(2):145-150. doi:10.1001/jama.281.2.145.
Original Contribution |  April 22, 1998 FREE
Low Molecular Weight Heparinoid, ORG 10172 (Danaparoid), and Outcome After Acute Ischemic Stroke:  A Randomized Controlled Trial
The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators
JAMA. 1998;279(16):1265-1272. doi:10.1001/jama.279.16.1265.
Original Contribution |  April 22, 1998 FREE
Cranial Computed Tomography Interpretation in Acute Stroke:  Physician Accuracy in Determining Eligibility for Thrombolytic Therapy
David L. Schriger, MD, MPH; Mary Kalafut, MD, MS; Sidney Starkman, MD; et al.
JAMA. 1998;279(16):1293-1297. doi:10.1001/jama.279.16.1293.
Special Communication |  April 22, 1998
Further Evolution Toward Effective Therapy for Acute Ischemic Stroke
Marc Fisher, MD; Julien Bogousslavsky, MD
JAMA. 1998;279(16):1298-1303. doi:10.1001/jama.279.16.1298.
Editorial |  March 04, 1998
Acetaminophen and Warfarin:  Undesirable Synergy
William R. Bell, MD
JAMA. 1998;279(9):702-703. doi:10.1001/jama.279.9.702.
Original Contribution |  March 04, 1998 FREE
Acetaminophen and Other Risk Factors for Excessive Warfarin Anticoagulation
Elaine M. Hylek, MD, MPH; Heather Heiman, BS; Steven J. Skates, PhD; et al.
JAMA. 1998;279(9):657-662. doi:10.1001/jama.279.9.657.
Review |  February 11, 1998 FREE
Risk of Fatal Pulmonary Embolism in Patients With Treated Venous Thromboembolism
James D. Douketis, MD, FRCPC; Clive Kearon, MB, FRCPC, PhD; Shannon Bates, MD, FRCPC; et al.
JAMA. 1998;279(6):458-462. doi:10.1001/jama.279.6.458.
From the Food and Drug Administration |  February 04, 1998
Two New Warnings Added to Labeling for Mibefradil
JAMA. 1998;279(5):346. doi:10.1001/jama.279.5.346.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Original Investigation  |  April 1, 2013
Use of Glucocorticoids and Risk of Venous Thromboembolism:  A Nationwide Population-Based Case-Control Study
Sigrun A. Johannesdottir, BSc; Erzsébet Horváth-Puhó, MSc, PhD; Olaf M. Dekkers, MD, PhD, MSc, MA; et al.
JAMA Internal Medicine
Editor's Correspondence  |  May 13, 2013
Resumption of Warfarin Therapy After Gastrointestinal Tract Bleeding: Benefit or Bias?
Kristian B. Filion, PhD; Jonathan Assayag, MSc; Laurent Azoulay, PhD
JAMA Internal Medicine
Editor's Correspondence  |  May 13, 2013
Resumption of Warfarin Therapy After Gastrointestinal Tract Bleeding: Benefit or Bias?—Reply
Daniel M. Witt, PharmD; Thomas Delate, PhD; Mark A. Crowther, MD
JAMA Internal Medicine
Editor's Correspondence  |  May 13, 2013
New Oral Anticoagulants in Acute Coronary Syndromes: What Does a Meta-analysis Tell Us?
Joey S. W. Kwong, PhD; Cheuk-Man Yu, MD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems